COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
‘The COVID-19 vaccine is based on the structural features of the receptor binding domain (RBD) on the virus' spike protein (S-protein).’
Tweet it Now
It uses genetic engineering to grow harmless copies of the virus S-protein to induce neutralising antibodies. The company said that recombinant vaccine technology is mature and suitable for large-scale production. The production does not require facilities with high biosafety levels since the process does not involve live viruses.
The recombinant vaccine is the company's third Covid-19 vaccine. Last December, an inactivated vaccine developed by the Beijing Biological Products Institute Co., Ltd. under CNBG became the first Chinese Covid-19 vaccine to have conditional marketing authorisation.
Shocking Imbalance of Covid-19 Vax Distribution Between Rich and Poor Countries
WHO Director General Tedros Adhanom Ghebreyesus warned that the world was facing a catastrophic moral failure over vaccine inequality earlier this year. Now, he criticizes over the distribution of coronavirus vaccines between rich and poor countries, as a shocking imbalance.
WHO Director General Tedros Adhanom Ghebreyesus warned that the world was facing a catastrophic moral failure over vaccine inequality earlier this year. Now, he criticizes over the distribution of coronavirus vaccines between rich and poor countries, as a shocking imbalance.
More than 161.12 million doses of Covid-19 vaccines had been administered across China as of Friday, the National Health Commission said on Saturday.
Advertisement
COVID-19 Update: Effective Shot Against Mutations can be Produced
The COVID-19 vaccine technology platform for Covaxin and Covishield, can develop effective effective vaccines against mutations.
The COVID-19 vaccine technology platform for Covaxin and Covishield, can develop effective effective vaccines against mutations.
Maharashtra COVID-19 Tally Crosses 33 Lakh
In Maharashtra COVID-19 tally has crossed the 33-lakh mark, while the death toll in Mumbai Metropolitan Region (MMR) zoomed past the 21,000-mark with over 30 lakh people under quarantine, reported sources.
In Maharashtra COVID-19 tally has crossed the 33-lakh mark, while the death toll in Mumbai Metropolitan Region (MMR) zoomed past the 21,000-mark with over 30 lakh people under quarantine, reported sources.
